R&D | April 15, 2026
Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
A major push to sharpen the future of cancer treatment is underway
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
The campaign builds on the three-year partnership unveiled earlier this season
The license is valid for five years, effective from April 9, 2026
Subscribe To Our Newsletter & Stay Updated
